Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine

CONCLUSION: Both the ChAdOx1- and BNT162b2-vaccinated groups showed high seropositivity for anti-S and neutralizing antibodies. The SIR of neutralizing antibodies in the ChAdOx1 vaccine group was higher in women than in men. Enhanced antibody responses were observed in participants vaccinated with BNT162b2 compared to those vaccinated with the ChAdOx1 vaccine.PMID:34845875 | DOI:10.3346/jkms.2021.36.e311

Source: Journal of Korean Medical Science - November 30, 2021 Category: Biomedical Science Authors: Yu Min Kang Dohsik Minn Jaegyun Lim Ki-Deok Lee Dong Ho Jo Kang-Won Choe Moon Jung Kim Jong Min Kim Kwang Nam Kim Source Type: research